Management of neurocysticercosis

Neurological Research

Volumn 32, Issue 3, 2010, Pages 229-237

  Ramírez Zamora, Adolfo ^a   Alarcón, Tomás ^b  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b CENTRO MÉDICO NACIONAL 20 DE NOVIEMBRE   (Mexico)

Author keywords

Brazil; Mexico; Neurocysticercosis; Taenia solium

Indexed keywords

ALBENDAZOLE; ALIN; CARBAMAZEPINE; DEXAMETHASONE; PHENYTOIN; PRAZIQUANTEL; PREDNISONE; UNCLASSIFIED DRUG;

BRAIN INFARCTION; BRAZIL; CESTODE; COGNITIVE DEFECT; CONSENSUS; CYST (RESTING STAGE); DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENCEPHALITIS; EPILEPSY; HEALTH CARE COST; HUMAN; INCIDENCE; INFECTION CONTROL; INTRACRANIAL HYPERTENSION; LIFE CYCLE; MEXICO; NEUROCYSTICERCOSIS; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PATIENT EDUCATION; PREVALENCE; REVIEW; SEIZURE; SPINAL CORD COMPRESSION; TAENIA SOLIUM;

ANTIPARASITIC AGENTS; DEVELOPING COUNTRIES; HUMANS; LATIN AMERICA; NEUROCYSTICERCOSIS;

EID: 77951215966     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164110X12644252260592     Document Type: Review

References (50)

1. Schantz P. Taenia solium Cysticercosis: An Overview of Global Distribution and Transmission, Oxon: CABI Publishing, 2002: pp. 63-74
2. del Brutto OH. Neurocysticercosis. Semin Neurol 2005; 25: 243-251
3. Flisser A. Taeniasis and cysticercosis due to Taenia solium. Prog Clin Parasitol 1994; 4: 77-116
4. Garcia HH, del Brutto OH. Neurocysticercosis: Updated concepts about an old disease. Lancet Neurol 2005; 4: 653-661
5. Larralde C, Padilla A, HernándezM, et al. Seroepidemiología de la neurocisticercosis en México. Epidemiología 1992; 34: 197-210
6. Cruz ME, Davis A, Dixin H, et al. Operational studies on the control of Taenia solium taeniasis cysticercosis in Ecuador. Bull World Heath Org 1989; 67: 401-407 (Pubitemid 19248542)
7. Diaz Camacho SP,Candil Ruiz A, Suate Peraza V, et al. Epidemiologic study and control of Taenia solium infections with Praziquantel in a rural village of Mexico. Am J Trop Med Hyg 1991; 45: 522-531
8. Velá squez-Pérez Leora, Cruz Olano JL, Juá rez Olivera SG. Neurocisticercosis: Algunos aspectos epidemioló gicos de los casos diagnosticados en el Instituto Nacional de Neurología y Neurocirugía 1995-2001. Rev Mex Neuroci 2004; 5: 426-433
9. Albores-Saavedra J, Altamirano-Dimas M. Algunas consideraciones sobre 9412 autopsias realizadas en el Hospital General de México. Gac Med Mex 1971; 102: 193-202
10. Fleury A, Morales J, Bobes RJ, et al. An epidemiological study of familial neurocysticercosis in an endemic Mexican community. Trans R Soc Trop Med Hyg 2006; 100: 551-558
11. Ortiz Trejo JM, Correa Chacón AJ, Sotelo Ham E. Factores de riesgo asociados con las neurocisticercosis en un hospital público de México. Gac Med Mex 2006; 142: 175-179
12. López Hernández A. Clinical manifestation and sequential computed tomography of cerebral cysticercosis in childhood. Brain Dev 1983; 5: 269-277 (Pubitemid 13028338)
13. Ruiz-García M, González-Astiazarán A, Rueda-Franco F. Neurocysticercosis in children clinical experience in 122 patients. Childs Nerv Syst 1997; 13: 608-612 (Pubitemid 28015844)
14. Gonzalez-Astiazarán A, Luna LN, Ruiz GM, et al. Neurocysticercosis in childhood: Clinical and pharmacological features. In: Fejerman N, Chamoles NA, eds. New Trends in Pediatric Neurology, Amsterdam: Elsevier Science, 1993: pp. 299-305
15. Benedeti MR, Falavigna DL, Falavigna-Guilherme AL, et al. Epidemiological and clinical profile of neurocysticercosis patients assisted by the Hospital Universitá rio Regional de Maringá , Paraná , Brazil. Arq Neuropsiquiatr 2007; 65: 124-129
16. Agapejev S. Aspectos clinico-epidemiologicos da Neurocisticercose no Brasil. Arq Neuropsiquiatr 2003; 61: 822-828
17. Sousa AQ, Sa HL, Queiroz TR, et al. Neurocysticercosis in Ceara state, Northeastern, Brazil: A review of 119 cases. Am J Trop Med Hyg 1998; 58: 759-762
18. Garcia-Noval J, Allan JC, Fletes C, et al. Epidemiology of Taenia solium taeniasis and cysticercosis in two rural Guatemalan communities. Am J Trop Med Hyg 1996 55: 282-289 (Pubitemid 26321833)
19. Arredondo F. Tomografía computarizada en el diagnó stico de cisticercosis. In: Aguilar F, ed. Cisticercosis. Guatemala City: Asociación Guatemalteca de Parasitologia y Medicina Tropical, 1981: pp. 51-55
20. Montano SM, Villaran MV, Ylquimiche L, et al. Neurocysticercosis, association between seizures, serology, and brain CT in rural Peru. Neurology 2005; 65: 229-234 (Pubitemid 41022366)
21. Garcia HH, Gonzalez AE, Gilman RH, et al. Short report: Transient antibody response in Taenia solium infection in field conditins-a major contributor to high seroprevalence. Am J Trop Med Hyg 2001; 65: 31-32
22. Hernández-Cossio O, Hernández-Fustes OJ. Neurocysticercosis and epilepsy in Cuba. Rev Neurol 1999; 29: 1003-1006
23. Acuña ER, Velasco Aparicio G, Guzmán Aranda G. Neurocisticercosis en Panamá. Rev Med Panamá 1988; 1: 9-16
24. Wallin MT, Kurtzke JF. Neurocysticercosis in the United States: Review of an important emerging infection. Neurology 2004; 63: 1559-1564
25. del Brutto OH, Roos KL, Coffey CS, et al. Meta-analysis: Cysticidal drugs for neurocysticercosis: Albendazole and praziquantel. Ann Intern Med 2006; 145: 43
26. Singh G, Sander J. Anticysticercal treatment and seizures in neurocysticercosis. Lancet Neurol 2004; 3: 207-208 (Pubitemid 38373658)
27. Alarcón F, Giménez-Roldán S. Systemic diseases that cause movement disorders. Parkinsonism Relat Disord 2005; 11: 1-18 (Pubitemid 40044691)
28. Forlenza OV, Filho AH, Nobrega JP, et al. Psychiatric manifestations of neurocysticercosis: A study of 38 patients from a neurology clinic in Brazil. J Neurol Neurosurg Psychiatry 1997; 62: 612-616
29. Singh O, Singghi S. Neurocystercosis in children. J Child Neurol 2004; 19: 482-492
30. Barboza M, Sepú lveda S, Montalvo D. Neurocisticercosis frontal déficit de atención. Colomb Med 2007; 38: 21-27
31. del Brutto OH, Wadia NH, Dumas M, et al. Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis. J Neurol Sci 1996; 142: 1-6 (Pubitemid 26340400)
32. Kramer LD, Locke GE, Byrd SE, et al. Cerebral cysticercosis: Documentation of natural history with CT. Radiology 1989; 171: 459-462
33. Nogales-Gaete J, Arriagada C, Salinas R. Tratamiento de la neurocisticercosis: Revisión critica. Rev Méd Chile 2006; 134: 789-796
34. Padma MV, Behari M, Misra NK, et al. Albendazole in neurocysticercosis. Natl Med J India 1995; 8: 255-258
35. Miller B, Grinnell V, Goldberg MA, et al. Spontaneous radiographic disappearance of cerebral cysticercosis: Three cases. Neurology 1983; 33: 1377-1379 (Pubitemid 13021212)
36. Salinas R, Prasad K. Drugs for treating neurocysticercosis (tapeworm infection of the brain), Oxford: Update Software, 2005
37. Carpio A, Kelvin EA, Bagiella E, et al. Effects of albendazole treatment on neurocysticercosis: A randomised controlled trial. J Neurol Neurosurg Psychiatry 2008; 79: 1050-1055
38. Garg RK. Medical management of neurocysticercosis. Neurol India 2001, 49: 329-337
39. del Brutto OH, Campos X, Sanchez J, et al. Single-day praziquantel versus one week albendazole for neurocysticercosis. Neurology 1999; 52: 1079-1081 (Pubitemid 29161627)
40. Garcia HH, Evans CA, Nash TE, et al. Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev 2002; 15: 747-756
41. Evans C, Garcia H, Gilman R, et al. Controversies in the management of cysticercosis. Emerg Infect Dis 1997; 3: 403-405
42. Salina R, Prasad D. Drugs for treating neurocysticercosis. Cochrane Database Syst Rev 2000: CD000215
43. Bang OY, Heo JH, Choi SA, et al. Large cerebral infarction during praziquantel therapy in neurocysticercosis. Stroke 1997; 28: 211-213 (Pubitemid 27039488)
44. Proaño J, Madrazo I, Avelar F, et al. Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts. N Engl J Med 2001; 345: 879-885
45. Jung H, Hurtado M, Sanchez M. Plasma and CSF levels of albendazole and praziquantel in patients with neurocysticercosis. Clin Neuropharmacol 1990, 13: 559-564
46. Kelley R, Duong D, Locke G. Characteristics of ventricular shunt malfunctions among patients with neurocysticercosis. Neurosurgery 2002; 50: 757-762 (Pubitemid 36322800)
47. Caplan L, Estanol B, Mitchel W, et al. How to manage patients with neurocysticercosis. Eur Neurol 1997; 37: 124-131 (Pubitemid 27077815)
48. Ahmad F, Sharma B. Treatment of intramedullary spinal cysticercosis: Report of 2 cases and review of the literature. Surg Neurol 2007; 67: 74-77 (Pubitemid 46038480)
49. Fleury A, Jefferson P, Marquez C. Tratamiento y manejo del enfermo neurocisticercoso. Cistimex 2006; 5: 1-3
50. Rodríguez-Leyva I, Juárez-Sanjuan A, Cuevas-Juárez E. Neurocisticercosis en un Hospital General en San Luis Potosí, México. Rev Ecuat Neurol 2000; 3: 45-48